CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems

Reflecting their importance in immunity, the activity of chemokines is regulated on several levels, including tissue and context-specific expression and availability of their cognate receptor on target cells. Chemokine synergism, affecting both chemokine and chemokine receptor function, has emerged...

Full description

Bibliographic Details
Main Authors: Ariadni Kouzeli, Paul J. Collins, Mieke Metzemaekers, Max Meyrath, Martyna Szpakowska, Marc Artinger, Sofie Struyf, Paul Proost, Andy Chevigne, Daniel F. Legler, Matthias Eberl, Bernhard Moser
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.561404/full
id doaj-8d35f8bfaebf42e1b147909a1f9e1d13
record_format Article
spelling doaj-8d35f8bfaebf42e1b147909a1f9e1d132020-11-25T04:00:33ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-10-011110.3389/fimmu.2020.561404561404CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor SystemsAriadni Kouzeli0Paul J. Collins1Mieke Metzemaekers2Max Meyrath3Martyna Szpakowska4Marc Artinger5Sofie Struyf6Paul Proost7Andy Chevigne8Daniel F. Legler9Matthias Eberl10Bernhard Moser11Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United KingdomInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United KingdomLaboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, BelgiumDepartment of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, LuxembourgDepartment of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, LuxembourgBiotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, SwitzerlandLaboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, BelgiumLaboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, BelgiumDepartment of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, LuxembourgBiotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, SwitzerlandDivision of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United KingdomDivision of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United KingdomReflecting their importance in immunity, the activity of chemokines is regulated on several levels, including tissue and context-specific expression and availability of their cognate receptor on target cells. Chemokine synergism, affecting both chemokine and chemokine receptor function, has emerged as an additional control mechanism. We previously demonstrated that CXCL14 is a positive allosteric modulator of CXCR4 in its ability to synergize with CXCL12 in diverse cellular responses. Here, we have extended our study to additional homeostatic, as well as a selection of inflammatory chemokine systems. We report that CXCL14 strongly synergizes with low (sub-active) concentrations of CXCL13 and CCL19/CCL21 in in vitro chemotaxis with immune cells expressing the corresponding receptors CXCR5 and CCR7, respectively. CXCL14 by itself was inactive, not only on cells expressing CXCR5 or CCR7 but also on cells expressing any other known conventional or atypical chemokine receptor, as assessed by chemotaxis and/or β-arrestin recruitment assays. Furthermore, synergistic migration responses between CXCL14 and inflammatory chemokines CXCL10/CXCL11 and CCL5, targeting CXCR3 and CCR5, respectively, were marginal and occasional synergistic Ca2+ flux responses were observed. CXCL14 bound to 300-19 cells and interfered with CCL19 binding to CCR7-expressing cells, suggesting that these cellular interactions contributed to the reported CXCL14-mediated synergistic activities. We propose a model whereby tissue-expressed CXCL14 contributes to cell localization under steady-state conditions at sites with prominent expression of homeostatic chemokines.https://www.frontiersin.org/article/10.3389/fimmu.2020.561404/fullchemokinessignal transductionsynergismmigrationcell localizationCXCR4
collection DOAJ
language English
format Article
sources DOAJ
author Ariadni Kouzeli
Paul J. Collins
Mieke Metzemaekers
Max Meyrath
Martyna Szpakowska
Marc Artinger
Sofie Struyf
Paul Proost
Andy Chevigne
Daniel F. Legler
Matthias Eberl
Bernhard Moser
spellingShingle Ariadni Kouzeli
Paul J. Collins
Mieke Metzemaekers
Max Meyrath
Martyna Szpakowska
Marc Artinger
Sofie Struyf
Paul Proost
Andy Chevigne
Daniel F. Legler
Matthias Eberl
Bernhard Moser
CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
Frontiers in Immunology
chemokines
signal transduction
synergism
migration
cell localization
CXCR4
author_facet Ariadni Kouzeli
Paul J. Collins
Mieke Metzemaekers
Max Meyrath
Martyna Szpakowska
Marc Artinger
Sofie Struyf
Paul Proost
Andy Chevigne
Daniel F. Legler
Matthias Eberl
Bernhard Moser
author_sort Ariadni Kouzeli
title CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
title_short CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
title_full CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
title_fullStr CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
title_full_unstemmed CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
title_sort cxcl14 preferentially synergizes with homeostatic chemokine receptor systems
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2020-10-01
description Reflecting their importance in immunity, the activity of chemokines is regulated on several levels, including tissue and context-specific expression and availability of their cognate receptor on target cells. Chemokine synergism, affecting both chemokine and chemokine receptor function, has emerged as an additional control mechanism. We previously demonstrated that CXCL14 is a positive allosteric modulator of CXCR4 in its ability to synergize with CXCL12 in diverse cellular responses. Here, we have extended our study to additional homeostatic, as well as a selection of inflammatory chemokine systems. We report that CXCL14 strongly synergizes with low (sub-active) concentrations of CXCL13 and CCL19/CCL21 in in vitro chemotaxis with immune cells expressing the corresponding receptors CXCR5 and CCR7, respectively. CXCL14 by itself was inactive, not only on cells expressing CXCR5 or CCR7 but also on cells expressing any other known conventional or atypical chemokine receptor, as assessed by chemotaxis and/or β-arrestin recruitment assays. Furthermore, synergistic migration responses between CXCL14 and inflammatory chemokines CXCL10/CXCL11 and CCL5, targeting CXCR3 and CCR5, respectively, were marginal and occasional synergistic Ca2+ flux responses were observed. CXCL14 bound to 300-19 cells and interfered with CCL19 binding to CCR7-expressing cells, suggesting that these cellular interactions contributed to the reported CXCL14-mediated synergistic activities. We propose a model whereby tissue-expressed CXCL14 contributes to cell localization under steady-state conditions at sites with prominent expression of homeostatic chemokines.
topic chemokines
signal transduction
synergism
migration
cell localization
CXCR4
url https://www.frontiersin.org/article/10.3389/fimmu.2020.561404/full
work_keys_str_mv AT ariadnikouzeli cxcl14preferentiallysynergizeswithhomeostaticchemokinereceptorsystems
AT pauljcollins cxcl14preferentiallysynergizeswithhomeostaticchemokinereceptorsystems
AT miekemetzemaekers cxcl14preferentiallysynergizeswithhomeostaticchemokinereceptorsystems
AT maxmeyrath cxcl14preferentiallysynergizeswithhomeostaticchemokinereceptorsystems
AT martynaszpakowska cxcl14preferentiallysynergizeswithhomeostaticchemokinereceptorsystems
AT marcartinger cxcl14preferentiallysynergizeswithhomeostaticchemokinereceptorsystems
AT sofiestruyf cxcl14preferentiallysynergizeswithhomeostaticchemokinereceptorsystems
AT paulproost cxcl14preferentiallysynergizeswithhomeostaticchemokinereceptorsystems
AT andychevigne cxcl14preferentiallysynergizeswithhomeostaticchemokinereceptorsystems
AT danielflegler cxcl14preferentiallysynergizeswithhomeostaticchemokinereceptorsystems
AT matthiaseberl cxcl14preferentiallysynergizeswithhomeostaticchemokinereceptorsystems
AT bernhardmoser cxcl14preferentiallysynergizeswithhomeostaticchemokinereceptorsystems
_version_ 1724449888961298432